I've been paying attention to the bemotrizinol conversation since the FDA approved it in June, and I finally sat down to work out what is holding up, what is hype, and what is on US shelves right now. Two brands have moved fast. Everyone else is still catching up. Here is what I've been learning, and here is where I would put my money if I were buying a new SPF this month.
Fair caveat before I go further: I am not a dermatologist. I am a midlife woman who reads the research and pays close attention to what is happening in the sunscreen category. If you know more about a specific formulation than I do, tell me and I will update the piece.
What bemotrizinol is.
Bemotrizinol (also called BEMT, sometimes sold under the brand name Parsol Shield) is a broad-spectrum UV filter. It protects against both UVA (the rays behind photoaging, pigmentation, and DNA damage tied to skin cancer risk) and UVB (the rays behind sunburn). In a single ingredient. That is unusual. Most sunscreen filters cover one part of the UV spectrum well and need to be layered with a second filter to cover the other part. Bemotrizinol covers both cleanly on its own, which makes it easier to formulate a well-protective sunscreen without needing a stack of six different filters to get there.
The molecule is large. Larger than the older chemical filters that have been in US sunscreens since the 1990s. Large enough that it is not readily absorbed through skin, which addresses the systemic absorption concerns that have been raised about older US chemical filters like oxybenzone and octinoxate. Bemotrizinol is also photostable, meaning it does not degrade in sunlight the way some older filters do. It is well-tolerated on most skin types including reactive and perimenopausal skin.
The safety data behind bemotrizinol is some of the strongest of any UV filter approved anywhere in the world. It has been used in Europe and Asia since 2000 with a substantial safety record across millions of users. If you have ever used La Roche-Posay Anthelios sold in France, ISDIN Eryfotona sold in Spain, or Bioderma Photoderm sold across Europe, you have used bemotrizinol. Americans have been travel-buying and mule-shipping these European formulas for over a decade because our own sunscreen category was so far behind. That is finally changing.
Why the US has been 25+ years behind.
The FDA regulates sunscreens as over-the-counter drugs rather than as cosmetics, which is how most of the rest of the world treats them. That distinction sounds bureaucratic but has meaningful consequences. New sunscreen filters have to go through the same approval pathway as new medications, which is slower, more expensive, and requires a higher evidentiary bar than the cosmetic pathway used in Europe and Asia.
The result: the FDA had not approved a new sunscreen filter in more than 25 years before June 2026, while Europe and Asia added roughly a dozen modern filters over the same period. American sunscreens have been stuck with a small set of aging chemical options (avobenzone, octinoxate, octisalate, homosalate, oxybenzone) or with mineral options (zinc oxide, titanium dioxide) that offered strong protection but often with a visible white cast that made daily wear harder for anyone with medium to deep skin tones.
Bemotrizinol changes the math. It is a modern chemical filter, broad-spectrum in a single molecule, invisible on skin, well-tolerated. The FDA approval on June 9, 2026 was the biggest news in the US sunscreen category since the 1990s, and it opens the door for a wave of new products through 2027 as brands reformulate their existing SPFs to include the new filter.
Bemotrizinol is the sunscreen filter Americans have been waiting for. It is not a novel ingredient, it is a modern ingredient that Europe and Asia already knew works. The interesting question now is which US brands move on it fastest and which formulations end up being worth the switch.
What is on US shelves right now.
As of early October 2026, two brands have bemotrizinol products you can buy in the US, and a third (La Roche-Posay) launches October 20, 2026. Everyone else is still working on their reformulation. Here is the honest read on each of the available options plus the imminent launch.
Ultra Violette is an Australian brand that has been a favorite of European and Australian skincare readers for years, and they moved fastest into the US bemotrizinol market. Unblock Screen launched at ultraviolettespf.com and sephora.com on August 31, 2026, and is now in Sephora stores nationwide. The formula is a zinc plus bemotrizinol combo (they are calling it a "skinscreen" because it doubles as a serum-lite layer), specifically formulated for reactive, oily, or breakout-prone skin. Soft-matte finish, no white cast, layers well under makeup.
The other reason to pay attention to Ultra Violette: their hero product, Fave Screen, launches with bemotrizinol in January 2027. Fave Screen has been the most-imported Australian sunscreen among US skincare readers for years, and a legitimate US launch is a meaningful event.
The first-mover prestige indie option. Worth trying if you have been importing Australian or European sunscreens for years, or if reactive/breakout-prone skin has kept you from finding a US chemical SPF that works.
Neutrogena (owned by Kenvue) launched two bemotrizinol-containing sunscreens on September 17, 2026, both using their Helioplex360 filter system which pairs bemotrizinol with additional UV filters for broader spectrum coverage. Ultra Sheer Daily is the multipurpose daily driver at SPF 70. Clear Face is the acne-friendly non-comedogenic option at SPF 60. Both are available at drugstores, Target, and Amazon at accessible prices, which makes Neutrogena the mass-retail winner of the first wave.
The accessible mass-retail bemotrizinol option. Not as elegant as a prestige formula but well-formulated at the price and available everywhere. If you want to try the new filter without a $40 commitment, this is the answer.
La Roche-Posay has confirmed an October 20, 2026 US launch for Anthelios UV Defense featuring bemotrizinol. This is a meaningful development because La Roche-Posay's Anthelios line has been the European dermatology benchmark for broad-spectrum chemical SPF for over a decade, and the US version has historically been a watered-down compromise built around the older filters available here. A properly bemotrizinol-containing US Anthelios closes that gap. If you have been importing European Anthelios for years, this is the launch to wait for.
Likely the dermatology-tier benchmark once it lands. If you want the strongest clinically backed European-style SPF now available in the US, this is worth waiting the two to three weeks for over the Neutrogena or Ultra Violette picks above.
What is coming from the brands you already use.
The rest of the industry is still working on it. Here is where the major midlife-favorite brands stand as of early October 2026, based on public announcements and industry reporting.
La Roche-Posay (launching October 20, 2026)
La Roche-Posay's European Anthelios line has used bemotrizinol for over a decade. Their US Anthelios line did not contain it because of the FDA approval issue. That gap closes on October 20, 2026, when Anthelios UV Defense with bemotrizinol launches in the US. Given the depth of La Roche-Posay's existing US market position and the clinical credibility of the Anthelios line in Europe, this is the launch most midlife skincare readers should wait for if they can hold off two more weeks. See the brand card above for the full read.
CeraVe (announced, no launch date)
CeraVe has publicly announced they are reformulating sunscreens to include bemotrizinol but has not published a US launch date. Given CeraVe's position as the most-recommended dermatologist mass-brand in the US, their bemotrizinol product will be significant when it lands. Watch for late 2026 or early 2027.
Supergoop (no announcement yet)
Supergoop has not publicly announced a bemotrizinol product timeline. As a US-based prestige sunscreen brand, they are one of the most-watched brands in the category, and the silence is noticeable. Whether they are working on something quietly or holding off strategically is not clear from the public information available.
ISDIN (no announcement yet)
ISDIN's European Eryfotona line has used bemotrizinol for years. Their US line, like La Roche-Posay's, does not currently contain the filter. No US bemotrizinol product announcement yet. ISDIN's dermatology-office distribution in the US means their eventual product will be an important prestige launch.
What to look for on the label.
Bemotrizinol will appear on ingredient lists under a few different names depending on how the brand chooses to write it. Bemotrizinol is the INCI name. Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine is the full chemical name. Tinosorb S is the trade name used in Europe. Parsol Shield is the DSM-Firmenich US brand name. If you see any of those on a US sunscreen label, you are looking at the new filter.
Percentage wise, bemotrizinol is approved for use up to 10% concentration in US sunscreens. Higher concentration generally means broader coverage. But formulation carries more weight than raw percentage, and a well-formulated 3% bemotrizinol combined with a supporting filter will often perform better than a 10% bemotrizinol used as the only active in an otherwise unremarkable formula.
Should you switch from your current sunscreen.
Not necessarily right now, and here is the honest read.
If your current SPF is a mineral (zinc oxide, titanium dioxide) formula and you tolerate it well, there is no urgent reason to switch. Mineral sunscreens still offer excellent broad-spectrum protection and are the safest option during pregnancy and for reactive skin. The bemotrizinol news is exciting but it does not obsolete zinc oxide.
Where bemotrizinol becomes especially useful is if you have been fighting with mineral sunscreen white cast for years, if you want a lighter chemical formula that layers better under makeup for daily wear, or if you have been importing European sunscreens because the US options were not working for your skin. In any of those cases, an Ultra Violette or Neutrogena bemotrizinol product this fall is worth trying, and a La Roche-Posay or CeraVe US bemotrizinol product in the next few months is worth waiting for if you want the dermatology-tier formulation.
The one group I would push toward bemotrizinol harder: midlife women who have been avoiding chemical sunscreens because of concerns about older filters (oxybenzone, octinoxate) but who also cannot tolerate the white cast or heavy feel of mineral formulas on aging skin. Bemotrizinol solves both problems. That is the audience the ingredient is quietly perfect for.
"Bemotrizinol is not a novel ingredient. It is a modern ingredient that Europe and Asia already knew works. The interesting question now is which US brands move on it fastest."
What I want to try.
My plan for the next 60 days: I want to test the Ultra Violette Unblock Screen SPF 50 as my daily driver through October and November. I have been using a zinc oxide sunscreen for the past year and I am curious whether the bemotrizinol formula wears better under makeup and reads more elegantly on midlife skin than the mineral formula does. I will report back at the 60-day mark.
Beyond that, I am watching the La Roche-Posay US launch closely, because a US Anthelios formula with bemotrizinol would be the single most consequential drugstore-accessible sunscreen launch of the decade. Whenever it lands, I will cover it as a follow-up piece.
What I still do not know.
There is plenty I want to be up front about not knowing yet. I do not know how bemotrizinol will perform in day-to-day US formulations across a full year of daily use (the European track record is strong but US formulations may end up different). I do not know when the prestige and dermatology-tier US brands will launch their bemotrizinol products, only that they have announced they are working on it. I do not know whether Supergoop or ISDIN will move on the ingredient at all, or whether they will hold with their existing formulations for competitive reasons.
What I do know is that this is the biggest positive change in the US sunscreen category in 25 years, that the Ultra Violette and Neutrogena launches are worth attention, and that anyone in midlife who has been dissatisfied with the current US sunscreen options has legitimate reason to be interested in what bemotrizinol makes possible.
Questions I've been getting.
What is bemotrizinol?
Bemotrizinol (BEMT, or Parsol Shield) is a broad-spectrum UV filter approved by the FDA in June 2026, the first new sunscreen active ingredient permitted in US sunscreens in more than 25 years. It protects against both UVA and UVB in a single molecule, is photostable, does not readily absorb through skin, and has been used in Europe and Asia since 2000 with a strong safety record.
What US sunscreens contain bemotrizinol right now?
As of September 2026, two brands: Ultra Violette (Unblock Screen SPF 50, launched Aug 31, available at Sephora starting Oct 2) and Neutrogena (Ultra Sheer Daily SPF 70 and Clear Face SPF 60, both launched Sept 17, using their Helioplex360 filter system).
When will La Roche-Posay, CeraVe, and Supergoop launch bemotrizinol products?
CeraVe and La Roche-Posay have both announced they are reformulating for the US market but have not published launch dates. Supergoop and ISDIN have not publicly announced US bemotrizinol timelines. The industry pipeline is expected to expand meaningfully through 2027.
Is bemotrizinol safe?
Bemotrizinol has some of the strongest safety data of any UV filter approved anywhere in the world. Used in Europe and Asia since 2000 across millions of users. The molecule is large enough that it is not readily absorbed through skin, which addresses systemic absorption concerns raised about some older US chemical filters.
Should I switch from my current sunscreen?
Not necessarily. If your current SPF is a mineral formula you tolerate well, there is no urgent reason to switch. Bemotrizinol becomes useful if you have struggled with mineral sunscreen white cast, if you want a lighter chemical formula for daily wear, or if you have been importing European sunscreens for years because the US options were not working.